Atea Pharmaceuticals Inc. (AVIR)
NASDAQ: AVIR
· Real-Time Price · USD
3.50
0.01 (0.29%)
At close: Aug 15, 2025, 3:59 PM
3.50
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT
Atea Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 416K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 192.18M | 32.81M | 60.39M | 65.98M |
Cost of Revenue | 104K | 104K | n/a | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 15.15M | 43K | 23K | 7K | 43.02M | 39.8M | 26.57M |
Gross Profit | -104K | -104K | 208K | -104K | -104K | -104K | -104K | -104K | -104K | -104K | -104K | -15.15M | -43K | -23K | 192.17M | -10.21M | 20.59M | 39.41M |
Operating Income | -41.34M | -39.04M | -39.03M | -37.2M | -46.92M | -69.81M | -46.57M | -40.78M | -35.23M | -41.57M | -39.9M | -16.28M | -32.3M | -42.17M | 121.18M | -22.15M | 8.69M | 30.66M |
Interest Income | 4.39M | 4.97M | 5.71M | 6.28M | 6.64M | 6.87M | 7.76M | 7.86M | 7.3M | 6.3M | 5.59M | 4.38M | 1.08M | 98K | 51K | 53K | 52K | 58K |
Pretax Income | -36.95M | -34.07M | -33.32M | -30.93M | -40.28M | -62.94M | -38.81M | -32.92M | -27.93M | -35.27M | -34.31M | -11.9M | -31.21M | -42.08M | 121.23M | -22.09M | 8.74M | 30.71M |
Net Income | -37.16M | -34.27M | -33.54M | -31.15M | -40.52M | -63.17M | -39.16M | -33.14M | -28.18M | -35.47M | -34.43M | -8.07M | -31.34M | -41.98M | 117.13M | -28.19M | 1.54M | 30.71M |
Selling & General & Admin | 9.07M | 9.46M | 13.36M | 11.04M | 12.12M | 12.13M | 11.42M | 12.6M | 13.17M | 12.62M | 12.36M | 11.38M | 12.44M | 12.54M | 13.19M | 11.94M | 11.9M | 8.76M |
Research & Development | 32.27M | 29.58M | 25.67M | 26.16M | 34.7M | 57.58M | 35.05M | 28.18M | 22.06M | 28.95M | 27.54M | 4.91M | 19.86M | 29.63M | 57.81M | 43.02M | 39.8M | 26.57M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 41.34M | 39.04M | 39.03M | 37.2M | 46.81M | 69.7M | 46.47M | 40.78M | 35.23M | 41.57M | 39.9M | 16.28M | 32.3M | 42.17M | 71M | 54.96M | 51.7M | 35.33M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -104K | -104K | -104K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.34M | 39.04M | 39.03M | 37.2M | 46.92M | 69.81M | 46.57M | 40.78M | 35.23M | 41.57M | 39.9M | 16.28M | 32.3M | 42.17M | 71M | 54.96M | 51.7M | 35.33M |
Income Tax Expense | 207K | -203K | 225K | 226K | 243K | 231K | 349K | 221K | 251K | 197K | 123K | -3.83M | 120K | -98K | 4.1M | 6.1M | 7.2M | n/a |
Shares Outstanding (Basic) | 83.75M | 85.16M | 84.46M | 84.42M | 84.25M | 83.92M | 83.44M | 83.4M | 83.4M | 83.33M | 83.29M | 83.26M | 83.26M | 83.18M | 83.1M | 82.82M | 82.74M | 82.58M |
Shares Outstanding (Diluted) | 83.75M | 85.16M | 84.46M | 84.42M | 84.25M | 83.92M | 83.44M | 83.4M | 83.4M | 83.33M | 83.29M | 83.26M | 83.26M | 83.18M | 87.09M | 82.82M | 88.09M | 89.1M |
EPS (Basic) | -0.44 | -0.4 | -0.4 | -0.37 | -0.48 | -0.75 | -0.47 | -0.4 | -0.34 | -0.43 | -0.41 | -0.1 | -0.38 | -0.5 | 1.41 | -0.34 | 0.02 | 0.37 |
EPS (Diluted) | -0.44 | -0.4 | -0.4 | -0.37 | -0.48 | -0.75 | -0.47 | -0.4 | -0.34 | -0.43 | -0.41 | -0.1 | -0.38 | -0.5 | 1.34 | -0.34 | 0.02 | 0.34 |
EBITDA | -41.34M | -39.04M | -33.21M | -37.2M | -46.92M | -69.7M | -38.71M | -40.78M | -35.23M | -41.47M | -34.2M | -16.28M | -32.3M | -42.17M | 121.19M | -22.14M | 8.7M | 30.66M |
EBIT | -36.95M | -34.07M | -33.32M | -37.2M | -46.92M | -69.81M | -38.81M | -40.78M | -35.23M | -41.57M | -39.9M | -11.9M | -32.3M | -42.17M | 121.18M | -22.15M | 8.74M | 30.71M |
Depreciation & Amortization | n/a | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 106K | 43K | 23K | 7K | 7K | 8K | 7K |